HarmonEyes, the AI-driven eye-tracking software innovator, announces the successful acquisition of iFocus Health, a clinically validated ADHD treatment monitoring solution that tracks eye movement to objectively assess patient response to medication. The iFocus platform addresses a longstanding challenge in ADHD care: the lack of reliable, real-time biomarkers to determine how well a treatment works. Traditionally, medication adjustments have relied on subjective self-reports, behavioral checklists, and provider observation — methods that leave patients and families guessing. iFocus shifted the paradigm by tracking subtle changes in eye movement during everyday activities like reading, providing clinicians with objective, actionable data.
Read the full article: HarmonEyes Completes Acquisition of iFocus Health, Bringing AI-Powered Clarity to ADHD Treatment //
Source: https://www.prnewswire.com/news-releases/harmoneyes-completes-acquisition-of-ifocus-health-bringing-ai-powered-clarity-to-adhd-treatment-302637181.html
